The Early Treatment and Intervention in Psychosis Study (TIPS) Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway; Department of Public Health, Faculty of Health Sciences, Network for Medical Sciences, University of Stavanger, Stavanger, Norway; Department of Psychiatry, Faculty of Medicine, Cairo University, Cairo, Egypt.
The Early Treatment and Intervention in Psychosis Study (TIPS) Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway; Department of Social Studies, Faculty of Social Sciences, University of Stavanger, Stavanger, Norway.
Lancet Psychiatry. 2023 Jul;10(7):528-536. doi: 10.1016/S2215-0366(23)00156-6.
Although the risk of suicidality is high in first-episode psychosis, patterns and individual variability in suicidal thoughts and behaviours over time are under-researched. We aimed to identify early trajectories of suicidality over a 2-year follow-up, assess their baseline predictors, and explore associations between those trajectories and later suicidality.
This longitudinal follow-up study was a part of the Early Treatment and Intervention in Psychosis (TIPS)study. Participants, linked to Norwegian and Danish death registries, were recruited from four catchment areas (665 000 inhabitants) in Norway and Denmark (both inpatient and outpatient). We included participants aged 15-65 years, with an intelligence quotient of more than 70, willing to give informed consent, and with a first episode of active psychotic symptoms. Individuals with comorbid neurological or endocrinal disorders, or those with contraindications to antipsychotics, were excluded. Growth mixture modelling was used to identify trajectories of suicidal thoughts and behaviours over the first 2 years. Multinomial logistic regression was applied to examine the baseline predictors of those trajectories and their associations with suicidality at 10-year follow-up.
A total of 301 participants were recruited from Jan 1, 1997, to Dec 31, 2000. Of the 299 with completed suicidality data at baseline, 271 participated in 1-year follow-up, 250 in 2-year follow-up, 201 in 5-year follow-up, and 186 at 10-year follow-up. At baseline, 176 (58%) were male, 125 (42%) were female. The mean age was 27·80 years (SD 9·64; range 15-63). 280 (93%) participants were of Scandinavian origin. Four trajectories over 2 years were identified: stable non-suicidal (217 [72%]), stable suicidal ideation (45 [15%]), decreasing suicidal thoughts and behaviours (21 [7%]), and worsening suicidal thoughts and behaviours (18 [6%]). A longer duration of untreated psychosis (odds ratio [OR] 1·24, 95% CI 1·02-1·50, p=0·033), poorer premorbid childhood social adjustment (1·33, 1·01-1·73, p=0·039), more severe depression (1·10, 1·02-1·20, p=0·016), and substance use (2·33, 1·21-4·46, p=0·011) at baseline predicted a stable suicidal ideation trajectory. Individuals in the stable suicidal ideation trajectory tended to have suicidal thoughts and behaviours at 10-year follow-up (3·12, 1·33-7·25, p=0·008). Individuals with a worsening suicidal trajectory were at a higher risk of death by suicide between 2 and 10 years (7·58, 1·53-37·62, p=0·013).
Distinct suicidal trajectories in first-episode psychosis were associated with specific predictors at baseline and distinct patterns of suicidality over time. Our findings call for early and targeted interventions for at-risk individuals with persistent suicidal ideation or deteriorating patterns of suicidal thoughts and behaviours, or both.
Health West, Norway; the Norwegian National Research Council; the Norwegian Department of Health and Social Affairs; the National Council for Mental Health and Health and Rehabilitation; the Theodore and Vada Stanley Foundation; the Regional Health Research Foundation for Eastern Region, Denmark; Roskilde County, Helsefonden, Lundbeck Pharma; Eli Lilly; Janssen-Cilag Pharmaceuticals, Denmark; a National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award and The National Institute of Mental Health grant; a National Alliance for Research on Schizophrenia & Depression Young Investigator Award from The Brain & Behavior Research Foundation; Health South East; Health West; and the Regional Centre for Clinical Research in Psychosis.
尽管首发精神病患者的自杀风险较高,但自杀意念和行为随时间变化的模式和个体差异仍研究不足。我们旨在确定 2 年随访期间自杀的早期轨迹,评估其基线预测因素,并探讨这些轨迹与随后自杀之间的关联。
这项纵向随访研究是早期治疗和干预精神病学(TIPS)研究的一部分。参与者与挪威和丹麦的死亡登记处相关联,从挪威和丹麦的四个(665000 名居民)集水区(门诊和住院患者)招募。我们纳入了年龄在 15-65 岁之间、智商高于 70、愿意提供知情同意且有活跃精神病症状首发的参与者。排除了合并神经或内分泌疾病的患者,或有抗精神病药物禁忌证的患者。增长混合模型用于确定自杀意念和行为在最初 2 年内的轨迹。多变量逻辑回归用于检验这些轨迹的基线预测因素及其与 10 年随访时自杀的关联。
从 1997 年 1 月 1 日至 2000 年 12 月 31 日,共招募了 301 名参与者。在基线时完成自杀数据的 299 名参与者中,271 名参加了 1 年随访,250 名参加了 2 年随访,201 名参加了 5 年随访,186 名参加了 10 年随访。基线时,176 名(58%)为男性,125 名(42%)为女性。平均年龄为 27.80 岁(标准差 9.64,范围 15-63)。280 名(93%)参与者为斯堪的纳维亚血统。在 2 年内确定了 4 种轨迹:稳定非自杀性(217 [72%])、稳定自杀意念(45 [15%])、自杀意念和行为减少(21 [7%])和自杀意念和行为恶化(18 [6%])。更长的未治疗精神病(优势比[OR]1.24,95%CI 1.02-1.50,p=0.033)、较差的童年社会适应能力(1.33,1.01-1.73,p=0.039)、更严重的抑郁(1.10,1.02-1.20,p=0.016)和物质使用(2.33,1.21-4.46,p=0.011)在基线时预测稳定的自杀意念轨迹。处于稳定自杀意念轨迹的个体在 10 年随访时往往有自杀想法和行为(3.12,1.33-7.25,p=0.008)。自杀轨迹恶化的个体在 2 至 10 年内自杀死亡的风险更高(7.58,1.53-37.62,p=0.013)。
首发精神病患者中不同的自杀轨迹与基线时的特定预测因素以及随时间变化的不同自杀模式相关。我们的发现呼吁对有持续自杀意念或自杀意念和行为恶化的高危个体进行早期和有针对性的干预,或者两者兼而有之。
西挪威健康基金会;挪威国家研究委员会;挪威卫生和社会事务部;国家心理健康和健康康复委员会;西奥多和瓦达·斯坦利基金会;丹麦罗斯基勒县、赫斯福登、Lundbeck 制药公司;礼来公司;詹森-赛拉吉制药公司,丹麦;国家精神分裂症和抑郁症研究联盟杰出研究员奖和美国国立卫生研究院资助;国家精神分裂症和抑郁症研究联盟青年研究员奖来自大脑与行为研究基金会;东南健康;西挪威健康;和精神疾病区域临床研究中心。